Navigating insurance approval for obesity medications is a critical part of my work as a physician dedicated to obesity medicine. Many insurance policies explicitly exclude coverage of these medications, posing a significant barrier for patients seeking effective treatment. Writing detailed appeals to insurance companies becomes essential to challenge these exclusions and ensure patients receive the care they deserve. From my experience, persistence and thorough documentation of the medical necessity of obesity medications greatly increase the likelihood of approval. Sharing patients’ health improvements, struggles with weight-related conditions, and evidence-based research supports these appeals. Educating patients about the complexities of insurance policies also empowers them to advocate for themselves. Obesity is a chronic disease that requires comprehensive treatment approaches, including medication when appropriate. Unfortunately, misconceptions and policy gaps often delay access to effective therapies. By consistently pushing for coverage, healthcare providers can reduce these delays and improve patient outcomes. This advocacy not only benefits individual patients but also raises awareness within the healthcare community about the importance of insurance reform related to obesity treatment. Ultimately, these efforts contribute to a more equitable healthcare system where obesity therapies are recognized as essential rather than optional.